Related Experiment Videos
Gender differences in the link between depression and cardiovascular disease
Tasneem Z Naqvi1, Syed S A Naqvi, C Noel Bairey Merz
1Division of Cardiology, Cedars-Sinai Research Institute, Cedars-Sinai Medical Center, University of California School of Medicine, Los Angeles, California, USA. tasneem.naqvi@cshs.org
Psychosomatic Medicine
|June 15, 2005
Summary
Major depression significantly increases cardiovascular mortality risk, especially in women with coronary heart disease. Serotonin reuptake inhibitors are safe and effective for treating depression post-acute myocardial infarction.
Area of Science:
- Cardiology and Psychiatry
- Understanding the interplay between cardiovascular disease and mental health.
Background:
- Cardiovascular disease (CVD) is a leading cause of death in the US, particularly affecting women.
- Major depression exacerbates cardiovascular mortality, with risks amplified in patients post-acute myocardial infarction (AMI) or unstable angina.
- Depression is more common in women with coronary heart disease (CHD), and social integration impacts cardiac event risk.
Purpose of the Study:
- To review the impact of major depression on cardiovascular mortality in men and women.
- To evaluate the efficacy and safety of various depression treatments in cardiovascular patients.
- To explore the specific challenges and treatment considerations for women with CVD and depression.
Main Methods:
- Literature review and synthesis of existing research on depression and cardiovascular disease.
- Analysis of epidemiological data and clinical trial outcomes.
- Examination of treatment effects (psychological, behavioral, and pharmacological) on cardiac prognosis.
Main Results:
- Major depression doubles the risk of cardiac death in patients with recent AMI or unstable angina.
- Psychological interventions may negatively impact prognosis in women post-AMI, unlike in men.
- Pharmacological treatment with serotonin reuptake inhibitors is safe and effective for depression in post-AMI patients, particularly those with recurrent depression.
Conclusions:
- Depression is a significant, modifiable risk factor for cardiovascular mortality.
- Serotonin reuptake inhibitors represent a safe and effective treatment option for depression in cardiovascular patients.
- Further research is needed to determine if effective depression treatment can ultimately reduce cardiac mortality.